机构:[1]Kunming Medical University, Kunming, China.[2]Department of Gastroenterology, First Affiliated Hospital of Dali University, Dali, China.[3]Department of Gastroenterology, First Affiliated Hospital of Kunming Medical University, Kunming, China.内科科室消化内科昆明医科大学附属第一医院[4]Yunnan Province Clinical Research Center for Digestive Diseases, Kunming, China.
National Natural Science Foundation of China
(U1802282, 81960108, 82170550, 82160107); Applied Basic Research Projects
of Yunnan Province [2019FE001(036)]; Medicine Leading Talent of Health and
Family Planning Commission of Yunnan Province (L-201607); Yunnan Health
Training Project of High Level Talents (H-2019050); Yunnan Ten Thousand Talents
Plan Young & Elite Talents Project; Yunnan Fundamental Research Projects
(202001BA070001-055).
第一作者机构:[1]Kunming Medical University, Kunming, China.[2]Department of Gastroenterology, First Affiliated Hospital of Dali University, Dali, China.[4]Yunnan Province Clinical Research Center for Digestive Diseases, Kunming, China.
共同第一作者:
通讯作者:
通讯机构:[3]Department of Gastroenterology, First Affiliated Hospital of Kunming Medical University, Kunming, China.[4]Yunnan Province Clinical Research Center for Digestive Diseases, Kunming, China.
推荐引用方式(GB/T 7714):
Ping Yan,Yang Sun,Juan Luo,et al.Integrating the serum proteomic and fecal metaproteomic to analyze the impacts of overweight/obesity on IBD: a pilot investigation[J].CLINICAL PROTEOMICS.2023,20(1):6.doi:10.1186/s12014-023-09396-y.
APA:
Ping Yan,Yang Sun,Juan Luo,Xiaolin Liu,Jing Wu&Yinglei Miao.(2023).Integrating the serum proteomic and fecal metaproteomic to analyze the impacts of overweight/obesity on IBD: a pilot investigation.CLINICAL PROTEOMICS,20,(1)
MLA:
Ping Yan,et al."Integrating the serum proteomic and fecal metaproteomic to analyze the impacts of overweight/obesity on IBD: a pilot investigation".CLINICAL PROTEOMICS 20..1(2023):6